Today Eli Lilly and Co. announced the FDA approval of Cymbalta (duloxetine HCI) for the management of fibromyalgia. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. This makes Cymbalta the second medication ever to be approved for fibromyalgia, following Lyrica’s approval in June 2007.
This is exciting news for fibromyalgia patients. No single medication or treatment is right for everyone, so the mor...
...U.S. Food and Drug Administration requesting that Cymbalta (duloxetine) be approved for the... Read more »
Generic name: Duloxetine Cymbalta is an antidepressant medication. It has been approved for use... Read more »
If Cymbalta (duloxetine) sounds familiar, it may be because it recently received FDA approval for... Read more »
The answer to this question is that they just might, especially if you are taking a certain type... Read more »
...the literature as not causing weight gain include Cymbalta and Serzone. If you find... Read more »
...response to treatment. To reduce your risk of side effects, your doctor may start you at a low... Read more »
(Ivanhoe Newswire) -- A new study reveals it is generally safe to stop anti-seizure medications in children with epilepsy who have been seizure-free... Read summary »
(Ivanhoe Newswire) ? Doctors who really want to help their patients kick the habit need to get aggressive. That's the take home message from two... Read summary »
(Ivanhoe Newswire) -- When a person tries a cigarette for the first time, he is either completely turned off by it or he becomes quickly addicted.... Read summary »
(Ivanhoe Newswire) ? New research may offer hope for extremely preterm infants. Advances in medical interventions have resulted in higher survival... Read summary »
(Ivanhoe Newswire) -- Nicotine addiction has reached its highest level within the last 15 years. Almost 75 percent of people currently being treated... Read summary »